Huadong Medicine Co (SZSE:000963) Research & Development: ¥1,588 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000963 Huadong Medicine Co Ltd SZSE:000963
88 GF Score
Price ¥27.31
GF Value ¥39.90
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Huadong Medicine Co Research & Development?

Huadong Medicine Co SZSE:000963 +0.11% 88 Research & Development is ¥1,588 Mil as of Mar. 2026. GuruFocus rates SZSE:000963 with a GF Score™ of 88/100 and a GF Value™ of ¥39.90 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Huadong Medicine Co's Research & Development for the three months ended in Mar. 2026 was ¥350 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥1,588 Mil.

Huadong Medicine Co  (SZSE:000963) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Huadong Medicine Co Research & Development Related Terms

Huadong Medicine Co Research & Development Historical Data

* Premium members only.

The historical data trend for Huadong Medicine Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huadong Medicine Co Research & Development Chart

Huadong Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 979.64 1,015.97 1,270.80 1,425.66 1,753.15

Huadong Medicine Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 515.38 484.30 507.92 245.56 350.37
SZSE:000963
88GF Score
Huadong Medicine Co Ltd SZSE:000963
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huadong Medicine Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,588 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥1,588 Mil mean?
Huadong Medicine Co (SZSE:000963) has a Research & Development of ¥1,588 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Huadong Medicine Co and its competitors.
Is Huadong Medicine Co's Research & Development too high?
Huadong Medicine Co's current Research & Development is ¥1,588 Mil. Overall, Huadong Medicine Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Huadong Medicine Co's Research & Development compare to ZTS?
Huadong Medicine Co's Research & Development of ¥1,588 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Huadong Medicine Co and its competitors. Huadong Medicine Co's current Research & Development is ¥1,588 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huadong Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Huadong Medicine Co (SZSE:000963) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥39.90, compared to a current price of ¥27.31 — trading 31.6% below its estimated fair value. The current Research & Development is ¥1,588 Mil. Huadong Medicine Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Huadong Medicine Co (SZSE:000963), the current Research & Development is ¥1,588 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Huadong Medicine Co (SZSE:000963) Overvalued in 2026?

Based on GuruFocus' analysis, Huadong Medicine Co stock appears to be undervalued. The current stock price of ¥27.31 is trading 31.6% below its estimated GF Value™ of ¥39.90. GuruFocus considers Huadong Medicine Co to be Significantly Undervalued.

Key valuation signals for SZSE:000963:

  • Research & Development: ¥1,588 Mil
  • GF Value™: ¥39.90 vs. price of ¥27.31 (31.6% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the SZSE:000963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Huadong Medicine Co Business Description

Address No. 866, Moganshan Road, Zhejiang Province, Hangzhou, CHN, 310011
Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drug products. The company mainly operates its business through three segments. The Manufacturing Business segment is engaged in the research and development, production, and marketing of specialized medicines, medicines for chronic diseases, as well as special medicines. The Commercial Business segment is engaged in the sales of medicines, medical devices, ginseng, and antler pieces. The International Medical Beauty Business segment is engaged in the production and sales of regeneration products, hyaluronic acids, and botulinum toxin products.
88GF Score

Get the complete analysis for SZSE:000963

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.31
Price
¥39.90
GF Value